Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
The deal bolsters capabilities in viral vector manufacturing for advanced cell and gene therapies.
deal
Resonance Health agrees to acquire TrialsWest
PCM Trials acquires EmVenio to boost decentralised clinical trials
Signal: Sanofi becomes latest pharma giant to spin off consumer healthcare business
Novo Nordisk spends $1bn to acquire weight loss drug developer Inversago
Deal focus: Biogen’s gambit to boost neurology portfolio with Reata acquisition
